Open AccessP1068: RISK‐ADJUSTED SAFETY ANALYSIS OF PACRITINIB IN PATIENTS WITH MYELOFIBROSIS
Author(s) -
Vannucchi A.,
Pemmaraju N.,
Scott B.,
Savona M.,
Oh S.,
Palandri F.,
AlAli H. K.,
Sobas M.,
McMullin M. F.,
Gupta V.,
Yacoub A.,
Mesa R.,
Buckley S.,
RomanTorres K.,
Verstovsek S.,
Harrison C.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000847140.81310.7b
Subject(s) - ruxolitinib , medicine , myelofibrosis , adverse effect , gastroenterology , bone marrow